HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
Hysigen Cat# TCH-C193, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
Hysigen |
TCH-C193 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-08-15 05:25:27 |
39236 |
BEAS-2B
Resource Report
Resource Website
1000+ mentions
|
Hysigen Cat# TCH-C132, RRID:CVCL_0168
|
Homo sapiens (Human)
|
|
Part of: Small cell lung cancer p53 hotspot mutation cell panel (ATCC TCP-2040)., Group: Patented cell line.
|
PMID:2450641 PMID:2539488 PMID:2846394 PMID:7972006 PMID:8504475 PMID:12894236 PMID:15463957 PMID:17331233 PMID:20215515 PMID:22521957 PMID:25524072 PMID:25877200 PMID:31156620 PMID:31900469
|
Transformed cell line
|
Male |
Beas-2B, BEAS 2B, BEAS2B, Beas2B, Bronchial Epithelium transformed with Ad12-SV40 2B |
Hysigen |
TCH-C132 |
BTO:BTO_0002923, CLO:CLO_0001925, EFO:EFO_0001089, MCCL:MCC:0000060, AddexBio:T0007001/26, ATCC:CRL-3588, ATCC:CRL-9609, BCRJ:0395, BioSample:SAMN03471073, BioSample:SAMN03472862, cancercelllines:CVCL_0168, CCRID:3101HUMSCSP5067, CCRID:5301HUM-KCB09022YJ, CCTCC:GDC0139, ChEMBL-Cells:CHEMBL4295386, ChEMBL-Targets:CHEMBL4296403, CLS:300311, ECACC:95102433, GEO:GSE33520, GEO:GSM139654, GEO:GSM139655, GEO:GSM139656, GEO:GSM139657, GEO:GSM139659, GEO:GSM139660, GEO:GSM139661, GEO:GSM139663, GEO:GSM139664, GEO:GSM139666, GEO:GSM171836, GEO:GSM171837, GEO:GSM253389, GEO:GSM827258, GEO:GSM3138797, GEO:GSM3138798, GEO:GSM3138799, GEO:GSM3138800, GEO:GSM3138801, GEO:GSM3138802, GEO:GSM3138803, GEO:GSM3138804, GEO:GSM3138805, Hysigen:TCH-C132, IARC_TP53:23556, KCB:KCB 200922YJ, Kerafast:ENH021-FP, Lonza:343, NCBI_Iran:C561, PRIDE:PXD003503, Progenetix:CVCL_0168, PubChem_Cell_line:CVCL_0168, Ubigene:YC-B005, Wikidata:Q54795940 |
|
|
CVCL_0168 |
2026-08-15 05:25:27 |
3359 |
Caco-2
Resource Report
Resource Website
5000+ mentions
|
RRID:CVCL_0025
|
Homo sapiens (Human)
|
Colon adenocarcinoma
|
Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257; PubMed=34339474)., Virology: Highly susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=15316659; PubMed=15731278)., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: ENCODE project common cell types; tier 3., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AstraZeneca Colorectal cell line (AZCL) panel.
|
PMID:327080 PMID:833871 PMID:2914637 PMID:3349466 PMID:3518877 PMID:6935474 PMID:7459858 PMID:7764660 PMID:8253353 PMID:8508948 PMID:9294210 PMID:10092214 PMID:10612807 PMID:10737795 PMID:11414198 PMID:11416159 PMID:11668190 PMID:12584437 PMID:14599474 PMID:15316659 PMID:15731278 PMID:15868485 PMID:16418264 PMID:16854228 PMID:16957166 PMID:18258742 PMID:20570890 PMID:20606684 PMID:20831567 PMID:21607810 PMID:23272949 PMID:23932154 PMID:24042735 PMID:24755471 PMID:25485619 PMID:25841592 PMID:25877200 PMID:25926053 PMID:25944804 PMID:25960936 PMID:26537799 PMID:26589293 PMID:26869432 PMID:28196595 PMID:28683746 PMID:29101300 PMID:29787057 PMID:30894373 PMID:31068700 PMID:31981602 PMID:33389257 PMID:34339474
|
Cancer cell line
|
Male |
CaCo-2, CACO-2, Caco 2, CACO 2, CACO2, CaCo2, CaCO2, Caco2, Caco-2/ATCC, Caco-II |
|
|
BTO:BTO_0000195, CLO:CLO_0002172, CLO:CLO_0050627, EFO:EFO_0001099, MCCL:MCC:0000120, CLDB:cl614, CLDB:cl615, CLDB:cl616, CLDB:cl617, CLDB:cl618, CLDB:cl619, CLDB:cl621, CLDB:cl5174, Abcam:ab275464, AddexBio:C0009009/29, ArrayExpress:E-MTAB-2706, ATCC:HTB-37, BCRJ:0059, BioSample:SAMN03473140, BioSample:SAMN05292461, BioSample:SAMN10989600, cancercelllines:CVCL_0025, CCRID:1101HUM-PUMC000100, CCRID:1102HUM-NIFDC00087, CCRID:3101HUMSCSP5027, CCRID:3101HUMTCHu146, CCRID:4201HUM-CCTCC00153, CCRID:5301HUM-KCB07010YJ, CCTCC:GDC0153, Cell_Model_Passport:SIDM00891, ChEMBL-Cells:CHEMBL3307519, ChEMBL-Targets:CHEMBL614058, CLS:300137, ColonAtlas:CACO2, Cosmic:720340, Cosmic:873696, Cosmic:875297, Cosmic:876709, Cosmic:887244, Cosmic:889531, Cosmic:948127, Cosmic:948829, Cosmic:983736, Cosmic:995392, Cosmic:1043805, Cosmic:1122320, Cosmic:1132564, Cosmic:1132694, Cosmic:1184081, Cosmic:1187299, Cosmic:1310931, Cosmic:1466811, Cosmic:1479620, Cosmic:1524334, Cosmic:1552180, Cosmic:1676742, Cosmic:1708415, Cosmic:1803940, Cosmic:1933015, Cosmic:2036652, Cosmic:2145574, Cosmic:2156940, Cosmic:2301543, Cosmic:2301964, Cosmic:2667879, Cosmic:2800568, DepMap:ACH-000003, DSMZ:ACC-169, DSMZCellDive:ACC-169, ECACC:09042001, ECACC:86010202, EGA:EGAS00001000610, EGA:EGAS00001002554, ENCODE:ENCBS311PHE, ENCODE:ENCBS390JMI, ENCODE:ENCBS391ENC, ENCODE:ENCBS530YXL, ENCODE:ENCBS700RKG, ENCODE:ENCBS890JZY, FANTOM5_SSTAR:10513-107D9, FCS-free:192-2-378-1-3-3, GEO:GSM206450, GEO:GSM274711, GEO:GSM274712, GEO:GSM274725, GEO:GSM383861, GEO:GSM472900, GEO:GSM472933, GEO:GSM513908, GEO:GSM514182, GEO:GSM741244, GEO:GSM749689, GEO:GSM749691, GEO:GSM749748, GEO:GSM784006, GEO:GSM843481, GEO:GSM843482, GEO:GSM845394, GEO:GSM945162, GEO:GSM945203, GEO:GSM945206, GEO:GSM945236, GEO:GSM1006210, GEO:GSM1006211, GEO:GSM1006212, GEO:GSM1346866, GEO:GSM1374426, GEO:GSM1448160, GEO:GSM2549989, GEO:GSM7701359, GEO:GSM7701360, IARC_TP53:21749, IBRC:C10094, ICLC:HTL97023, IZSLER:BS TCL 87, KCB:KCB 200710YJ, KCLB:30037.1, LINCS_LDP:LCL-1170, Lonza:36, MeSH:D018938, MetaboLights:MTBLS227, MetaboLights:MTBLS328, NCBI_Iran:C139, PharmacoDB:Caco2_161_2019, PRIDE:PXD001550, PRIDE:PXD005354, PRIDE:PXD005355, PRIDE:PXD018357, PRIDE:PXD019645, PRIDE:PXD023760, Progenetix:CVCL_0025, PubChem_Cell_line:CVCL_0025, RCB:RCB0988, TOKU-E:762, Ubigene:YC-D003, Wikidata:Q5016050 |
|
|
CVCL_0025 |
2026-08-15 04:19:53 |
9197 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
ATCC Cat# HTB-47, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
ATCC |
HTB-47 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:56 |
278 |
CAL-120
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1104
|
Homo sapiens (Human)
|
Breast carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:20164919 PMID:20215515 PMID:22460905 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30613774 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
CAL 120, CAL120 |
|
|
CLO:CLO_0002179, EFO:EFO_0005356, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-6647, BioGRID_ORCS_Cell_line:166, BioSample:SAMN03472991, BioSample:SAMN03473555, BioSample:SAMN10989564, cancercelllines:CVCL_1104, Cell_Model_Passport:SIDM00940, ChEMBL-Cells:CHEMBL3308577, ChEMBL-Targets:CHEMBL1075405, Cosmic:906826, Cosmic:1995355, Cosmic:2164984, Cosmic-CLP:906826, DepMap:ACH-000212, DSMZ:ACC-459, DSMZCellDive:ACC-459, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:906826, GEO:GSM274647, GEO:GSM274665, GEO:GSM344361, GEO:GSM344411, GEO:GSM783963, GEO:GSM827160, GEO:GSM843483, GEO:GSM847210, GEO:GSM847455, GEO:GSM886904, GEO:GSM887969, GEO:GSM1172944, GEO:GSM1669645, IARC_TP53:21208, LiGeA:CCLE_802, LINCS_HMS:51110, LINCS_LDP:LCL-1463, PharmacoDB:CAL120_165_2019, PRIDE:PXD030304, Progenetix:CVCL_1104, PubChem_Cell_line:CVCL_1104, SLKBase:3487, Wikidata:Q54808384 |
|
|
CVCL_1104 |
2026-08-15 04:19:56 |
20 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
ICLC Cat# HTL95029, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
ICLC |
HTL95029 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:56 |
278 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
DSMZ Cat# ACC-54, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
DSMZ |
ACC-54 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:56 |
278 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
BCRJ Cat# 0408, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
BCRJ |
0408 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:59 |
278 |
CAL-12T
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1105
|
Homo sapiens (Human)
|
Lung non-small cell carcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1657424 PMID:2145926 PMID:2440566 PMID:18083107 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:29681454 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
Cal-12T, Cal.12T, CAL 12T, CAL12T, Cal12T, CAL 12, Centre Antoine Lacassagne-12T |
|
|
CLO:CLO_0002180, EFO:EFO_0006547, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473097, BioSample:SAMN10987846, cancercelllines:CVCL_1105, Cell_Model_Passport:SIDM00939, ChEMBL-Cells:CHEMBL3308132, ChEMBL-Targets:CHEMBL1075406, Cosmic:753540, Cosmic:1995356, Cosmic-CLP:753540, DepMap:ACH-000826, DSMZ:ACC-443, DSMZCellDive:ACC-443, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:753540, GEO:GSM784241, GEO:GSM827248, GEO:GSM886905, GEO:GSM887970, GEO:GSM1669646, IARC_TP53:21209, LiGeA:CCLE_097, LINCS_LDP:LCL-1603, PharmacoDB:CAL12T_166_2019, PRIDE:PXD030304, Progenetix:CVCL_1105, PubChem_Cell_line:CVCL_1105, Wikidata:Q54808385 |
|
|
CVCL_1105 |
2026-08-15 04:19:56 |
2 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
KCLB Cat# 30047, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
KCLB |
30047 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:59 |
278 |
CAL-54
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-365, RRID:CVCL_1111
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8868943 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Male |
CAL 54, CAL54, Centre Antoine Lacassagne-54 |
DSMZ |
ACC-365 |
CLO:CLO_0002186, EFO:EFO_0002125, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473166, BioSample:SAMN10988487, cancercelllines:CVCL_1111, Cell_Model_Passport:SIDM00932, ChEMBL-Cells:CHEMBL3308346, ChEMBL-Targets:CHEMBL1075412, Cosmic:910952, Cosmic-CLP:910952, DepMap:ACH-000457, DSMZ:ACC-365, DSMZCellDive:ACC-365, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910952, GEO:GSM886910, GEO:GSM887976, GEO:GSM1669653, IARC_TP53:21212, IGRhCellID:CAL54, LiGeA:CCLE_129, LINCS_LDP:LCL-1757, PharmacoDB:CAL54_173_2019, PRIDE:PXD030304, Progenetix:CVCL_1111, PubChem_Cell_line:CVCL_1111, Wikidata:Q54808409 |
|
|
CVCL_1111 |
2026-08-15 04:19:56 |
1 |
Calu-6
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0236
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1855224 PMID:2388294 PMID:3129183 PMID:3335022 PMID:3518877 PMID:3940644 PMID:6148444 PMID:6935474 PMID:7459858 PMID:7834619 PMID:7972006 PMID:8385084 PMID:12068308 PMID:12794755 PMID:20164919 PMID:20215515 PMID:20679594 PMID:22460905 PMID:22961666 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28273808 PMID:29681454 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
CaLu-6, CALU-6, Calu.6, Calu 6, Calu6, CALU6, CaLu-06 |
|
|
BTO:BTO_0002235, CLO:CLO_0002193, EFO:EFO_0002152, MCCL:MCC:0000125, CLDB:cl636, CLDB:cl638, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-56, BioGRID_ORCS_Cell_line:587, BioSample:SAMN03473148, BioSample:SAMN10987791, cancercelllines:CVCL_0236, CancerTools:161924, CCRID:1101HUM-PUMC000813, CCRID:3101HUMTCHu144, Cell_Model_Passport:SIDM00921, ChEMBL-Cells:CHEMBL3307639, ChEMBL-Targets:CHEMBL614535, CLS:300135, Cosmic:724859, Cosmic:929969, Cosmic:933575, Cosmic:934466, Cosmic:934542, Cosmic:1071885, Cosmic:1089230, Cosmic:1146874, Cosmic:1176611, Cosmic:1434959, Cosmic:1995360, Cosmic:2668262, Cosmic-CLP:724859, DepMap:ACH-000264, DSMZ:ACC-734, DSMZCellDive:ACC-734, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:724859, GEO:GSM108805, GEO:GSM108806, GEO:GSM253341, GEO:GSM434325, GEO:GSM513938, GEO:GSM514319, GEO:GSM794263, GEO:GSM817065, GEO:GSM843487, GEO:GSM886916, GEO:GSM887982, GEO:GSM1374435, GEO:GSM1374436, GEO:GSM1669659, IARC_TP53:119, IARC_TP53:21265, ICLC:HTL97003, IGRhCellID:Calu6, KCLB:30056, LiGeA:CCLE_215, LINCS_LDP:LCL-1626, Lonza:1139, NCBI_Iran:C431, PharmacoDB:Calu6_180_2019, PRIDE:PXD025499, PRIDE:PXD030304, Progenetix:CVCL_0236, PubChem_Cell_line:CVCL_0236, Wikidata:Q54808427 |
|
|
CVCL_0236 |
2026-08-15 04:19:57 |
35 |
CAL-27
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1107
|
Homo sapiens (Human)
|
Tongue adenosquamous carcinoma
|
Population: Caucasian., Part of: OPC-22 oral and pharyngeal cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2145926 PMID:2440566 PMID:3181269 PMID:19631575 PMID:20014447 PMID:20164919 PMID:21868764 PMID:22460905 PMID:24201445 PMID:25275298 PMID:25485619 PMID:25877200 PMID:25888065 PMID:26589293 PMID:27108184 PMID:27397505 PMID:28196595 PMID:28476783 PMID:29156801 PMID:29770536 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:34977030 PMID:35839778 PMID:36912284
|
Cancer cell line
|
Male |
Cal-27, CAL 27, Cal 27, CAL27, Cal27, CAL-SCC-27, Centre Antoine Lacassagne-27 |
|
|
BTO:BTO_0000921, CLO:CLO_0002178, CLO:CLO_0002182, EFO:EFO_0006366, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2095, BCRJ:0326, BioGRID_ORCS_Cell_line:336, BioSample:SAMN03471886, BioSample:SAMN10987905, cancercelllines:CVCL_1107, CCRID:1101HUM-PUMC000338, CCRID:4201HUM-CCTCC00248, CCTCC:GDC0248, Cell_Model_Passport:SIDM00937, ChEMBL-Cells:CHEMBL3308098, ChEMBL-Targets:CHEMBL1075408, CLS:305029, Cosmic:686972, Cosmic:910916, Cosmic:1006469, Cosmic:1017793, Cosmic:1041674, Cosmic:1339913, Cosmic:1466800, Cosmic:1530734, Cosmic:1752762, Cosmic:2043896, Cosmic:2131842, Cosmic:2296292, Cosmic-CLP:910916, DepMap:ACH-000832, DSMZ:ACC-446, DSMZCellDive:ACC-446, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910916, GEO:GSM422868, GEO:GSM423671, GEO:GSM886907, GEO:GSM887972, GEO:GSM1374427, GEO:GSM1374428, GEO:GSM1519074, GEO:GSM1519075, GEO:GSM1519076, GEO:GSM1669648, IARC_TP53:17482, IGRhCellID:CAL27%20GSE9585, LiGeA:CCLE_698, LINCS_LDP:LCL-1215, PharmacoDB:CAL27_168_2019, PRIDE:PXD002132, PRIDE:PXD028810, PRIDE:PXD029420, PRIDE:PXD030304, Progenetix:CVCL_1107, PubChem_Cell_line:CVCL_1107, Wikidata:Q54808394 |
|
|
CVCL_1107 |
2026-08-15 04:19:59 |
368 |
CAL-54
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1111
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8868943 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Male |
CAL 54, CAL54, Centre Antoine Lacassagne-54 |
|
|
CLO:CLO_0002186, EFO:EFO_0002125, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473166, BioSample:SAMN10988487, cancercelllines:CVCL_1111, Cell_Model_Passport:SIDM00932, ChEMBL-Cells:CHEMBL3308346, ChEMBL-Targets:CHEMBL1075412, Cosmic:910952, Cosmic-CLP:910952, DepMap:ACH-000457, DSMZ:ACC-365, DSMZCellDive:ACC-365, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910952, GEO:GSM886910, GEO:GSM887976, GEO:GSM1669653, IARC_TP53:21212, IGRhCellID:CAL54, LiGeA:CCLE_129, LINCS_LDP:LCL-1757, PharmacoDB:CAL54_173_2019, PRIDE:PXD030304, Progenetix:CVCL_1111, PubChem_Cell_line:CVCL_1111, Wikidata:Q54808409 |
|
|
CVCL_1111 |
2026-08-15 04:19:56 |
1 |
CAMA-1
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1115
|
Homo sapiens (Human)
|
Breast adenocarcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:833871 PMID:924690 PMID:3518877 PMID:6582512 PMID:6935474 PMID:7017212 PMID:7459858 PMID:10862037 PMID:11343771 PMID:12353263 PMID:12661003 PMID:12800145 PMID:16397213 PMID:16541312 PMID:17157791 PMID:18516279 PMID:19593635 PMID:20164919 PMID:20215515 PMID:22460905 PMID:22585861 PMID:23601657 PMID:24094812 PMID:24162158 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
Cama-1, CAMA1, CAMA |
|
|
BTO:BTO_0005022, CLO:CLO_0002194, EFO:EFO_0001100, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:HTB-21, BioGRID_ORCS_Cell_line:588, BioSample:SAMN03472698, BioSample:SAMN10987851, cancercelllines:CVCL_1115, CancerTools:161925, Cell_Model_Passport:SIDM00920, ChEMBL-Cells:CHEMBL3308719, ChEMBL-Targets:CHEMBL1075416, Cosmic:687468, Cosmic:871153, Cosmic:904354, Cosmic:946382, Cosmic:997930, Cosmic:1000130, Cosmic:1046925, Cosmic:1047717, Cosmic:1136349, Cosmic:1287905, Cosmic:1289386, Cosmic:1603195, Cosmic:1995361, Cosmic:2165018, Cosmic:2750520, Cosmic-CLP:946382, DepMap:ACH-000783, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:946382, GEO:GSM344344, GEO:GSM344394, GEO:GSM378143, GEO:GSM421864, GEO:GSM783930, GEO:GSM827295, GEO:GSM843488, GEO:GSM843489, GEO:GSM847248, GEO:GSM847458, GEO:GSM886917, GEO:GSM887983, GEO:GSM984230, GEO:GSM1008894, GEO:GSM1053694, GEO:GSM1172856, GEO:GSM1172948, GEO:GSM1215264, GEO:GSM1238119, GEO:GSM1374437, GEO:GSM1661977, GEO:GSM1669660, IARC_TP53:18372, LiGeA:CCLE_527, LINCS_HMS:50131, LINCS_LDP:LCL-1466, Lonza:1251, PharmacoDB:CAMA1_181_2019, PRIDE:PXD002486, PRIDE:PXD030304, Progenetix:CVCL_1115, PubChem_Cell_line:CVCL_1115, SLKBase:3405, Wikidata:Q54808432 |
|
|
CVCL_1115 |
2026-08-15 04:19:57 |
31 |
CAL-51
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1110
|
Homo sapiens (Human)
|
Breast carcinoma
|
Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=34339474)., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:2390488 PMID:10969801 PMID:11044355 PMID:12661003 PMID:12800145 PMID:15677628 PMID:19582160 PMID:20164919 PMID:20215515 PMID:21778573 PMID:22460905 PMID:22585861 PMID:23122841 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:34339474 PMID:35839778 PMID:36476833
|
Cancer cell line
|
Female |
CAL 51, CAL51, Cal51, Centre Antoine Lacassagne-51 |
|
|
BTO:BTO_0000945, CLO:CLO_0002185, EFO:EFO_0005358, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:585, BioSample:SAMN03473159, BioSample:SAMN10988576, cancercelllines:CVCL_1110, Cell_Model_Passport:SIDM00933, ChEMBL-Cells:CHEMBL3308717, ChEMBL-Targets:CHEMBL1075411, Cosmic:687467, Cosmic:910927, Cosmic:1057761, Cosmic:2164986, Cosmic-CLP:910927, DepMap:ACH-000856, DSMZ:ACC-302, DSMZCellDive:ACC-302, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:910927, GEO:GSM115099, GEO:GSM217567, GEO:GSM274645, GEO:GSM274646, GEO:GSM344362, GEO:GSM344412, GEO:GSM350521, GEO:GSM459702, GEO:GSM783973, GEO:GSM827162, GEO:GSM847246, GEO:GSM847456, GEO:GSM886909, GEO:GSM887975, GEO:GSM1172946, GEO:GSM1374429, GEO:GSM1664565, GEO:GSM1669652, IARC_TP53:21211, IGRhCellID:CAL51, LiGeA:CCLE_143, LINCS_HMS:50008, LINCS_LDP:LCL-1472, Lonza:1002, PharmacoDB:CAL51_172_2019, PRIDE:PXD000953, PRIDE:PXD030304, Progenetix:CVCL_1110, PubChem_Cell_line:CVCL_1110, SLKBase:3399, Wikidata:Q54808406 |
|
|
CVCL_1110 |
2026-08-15 04:19:56 |
39 |
Calu-1
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_0608
|
Homo sapiens (Human)
|
Lung squamous cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080 PMID:833871 PMID:3518877 PMID:6582512 PMID:6935474 PMID:7017212 PMID:7459858 PMID:7736387 PMID:7972006 PMID:8385084 PMID:11583962 PMID:12068308 PMID:12794755 PMID:20164919 PMID:20215515 PMID:22460905 PMID:22961666 PMID:24002593 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26361996 PMID:26589293 PMID:28196595 PMID:29681454 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CaLu-1, CALU-1, Calu.1, CALU 1, Calu 1, CALU1, Calu1 |
|
|
BTO:BTO_0002940, CLO:CLO_0002191, EFO:EFO_0002151, CLDB:cl631, CLDB:cl632, CLDB:cl633, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-54, BioGRID_ORCS_Cell_line:233, BioSample:SAMN03471732, BioSample:SAMN10988371, cancercelllines:CVCL_0608, CancerTools:161905, CCRID:3101HUMTCHu192, Cell_Model_Passport:SIDM01545, ChEMBL-Cells:CHEMBL3308031, ChEMBL-Targets:CHEMBL613505, CLS:300141, Cosmic:724858, Cosmic:755615, Cosmic:929968, Cosmic:933574, Cosmic:934465, Cosmic:934541, Cosmic:1089224, Cosmic:1146872, Cosmic:1188586, Cosmic:1434968, Cosmic:2060525, Cosmic:2125218, Cosmic:2645023, Cosmic:2646653, Cosmic:2668264, Cosmic:2772160, DepMap:ACH-000511, ECACC:93120818, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:724858, GEO:GSM108801, GEO:GSM108802, GEO:GSM206451, GEO:GSM253387, GEO:GSM274735, GEO:GSM274736, GEO:GSM434324, GEO:GSM784250, GEO:GSM794261, GEO:GSM817063, GEO:GSM843486, GEO:GSM886914, GEO:GSM887980, GEO:GSM1374430, GEO:GSM1374431, GEO:GSM1374432, IARC_TP53:8200, IARC_TP53:21263, ICLC:HTL95002, IGRhCellID:Calu1, IZSLER:BS TCL 76, LiGeA:CCLE_612, LINCS_HMS:50009, LINCS_LDP:LCL-1580, PharmacoDB:Calu1_178_2019, PRIDE:PXD002556, Progenetix:CVCL_0608, PubChem_Cell_line:CVCL_0608, Wikidata:Q54808423 |
|
|
CVCL_0608 |
2026-08-15 04:19:59 |
212 |
CAL-85-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1114
|
Homo sapiens (Human)
|
Breast carcinoma
|
Population: Asian., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7531416 PMID:20164919 PMID:20215515 PMID:22460905 PMID:24176112 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Female |
Cal-85-1, CAL 85-1, CAL85-1, CAL851, Centre Antoine Lacassagne-85-1 |
|
|
CLO:CLO_0002190, EFO:EFO_0005359, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473094, BioSample:SAMN10988345, cancercelllines:CVCL_1114, Cell_Model_Passport:SIDM00928, ChEMBL-Cells:CHEMBL3308700, ChEMBL-Targets:CHEMBL1075415, Cosmic:910852, Cosmic:2164987, Cosmic-CLP:910852, DepMap:ACH-000857, DSMZ:ACC-440, DSMZCellDive:ACC-440, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:910852, GEO:GSM274639, GEO:GSM344363, GEO:GSM344413, GEO:GSM827163, GEO:GSM843484, GEO:GSM843485, GEO:GSM847247, GEO:GSM847457, GEO:GSM886913, GEO:GSM887979, GEO:GSM1172947, GEO:GSM1669657, IARC_TP53:21215, LiGeA:CCLE_496, LINCS_HMS:51112, LINCS_LDP:LCL-1465, Lonza:1212, PharmacoDB:CAL851_177_2019, Progenetix:CVCL_1114, PubChem_Cell_line:CVCL_1114, Wikidata:Q54808414 |
|
|
CVCL_1114 |
2026-08-15 04:19:56 |
8 |
Caov-4
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_0202
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: TCGA-110-CL cell line panel., Part of: OCCP ovarian cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3518877 PMID:6935474 PMID:9698466 PMID:20164919 PMID:20204287 PMID:20215515 PMID:22460905 PMID:23839242 PMID:25230021 PMID:25877200 PMID:25984343 PMID:27235858 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Female |
CaOv-4, CaOV-4, CAOV-4, CAOV4, Caov4 |
|
|
CLO:CLO_0002196, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-76, BioGRID_ORCS_Cell_line:843, BioSample:SAMN03472755, BioSample:SAMN03472784, BioSample:SAMN10987815, cancercelllines:CVCL_0202, CancerTools:161927, CCRID:1101HUM-PUMC000367, Cell_Model_Passport:SIDM00918, ChEMBL-Cells:CHEMBL3308232, ChEMBL-Targets:CHEMBL2366249, Cosmic:688093, Cosmic:809112, Cosmic:844350, Cosmic:849610, Cosmic:948287, Cosmic:949090, Cosmic:949226, Cosmic:1305321, Cosmic-CLP:949090, DepMap:ACH-000103, EGA:EGAS00001000978, GDSC:949090, GEO:GSM784562, GEO:GSM886919, GEO:GSM887985, GEO:GSM1001487, GEO:GSM1291131, GEO:GSM1669662, IARC_TP53:1414, IARC_TP53:28484, IARC_TP53:30198, IGRhCellID:Caov4, IZSLER:BS TCL 183, KCLB:30076, LiGeA:CCLE_173, LINCS_LDP:LCL-1520, NCBI_Iran:C595, PharmacoDB:Caov4_183_2019, PRIDE:PXD030304, Progenetix:CVCL_0202, PubChem_Cell_line:CVCL_0202, Wikidata:Q54808586 |
|
|
CVCL_0202 |
2026-08-15 04:20:01 |
5 |
Caov-3
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_0201
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: OCCP ovarian cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3335022 PMID:3518877 PMID:4016745 PMID:9698466 PMID:10318951 PMID:12080474 PMID:18560578 PMID:19926575 PMID:20164919 PMID:20204287 PMID:20215515 PMID:22328975 PMID:22460905 PMID:22710073 PMID:23415752 PMID:23839242 PMID:24023729 PMID:25230021 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27235858 PMID:27397505 PMID:27561551 PMID:28196595 PMID:30485824 PMID:30894373 PMID:31068700 PMID:31978347 PMID:33519462 PMID:35681748 PMID:35839778
|
Cancer cell line
|
Female |
CaOv-3, CaOV-3, CAOV-3, CAOV3, CaOV3, CaOv3, Caov3, CA-OV-3, CaOV3 (S) |
|
|
BTO:BTO_0000814, CLO:CLO_0002195, EFO:EFO_0002148, MCCL:MCC:0000119, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-75, BioGRID_ORCS_Cell_line:338, BioSample:SAMN03472624, BioSample:SAMN05292465, BioSample:SAMN10988200, cancercelllines:CVCL_0201, CancerTools:161926, CCRID:1101HUM-PUMC000339, CCRID:3101HUMSCSP570, CCRID:4201HUM-CCTCC00118, CCTCC:GDC0118, Cell_Model_Passport:SIDM00919, ChEMBL-Cells:CHEMBL3307927, ChEMBL-Targets:CHEMBL614379, CLS:300319, Cosmic:687927, Cosmic:688092, Cosmic:809114, Cosmic:844349, Cosmic:906579, Cosmic:906825, Cosmic:924149, Cosmic:949225, Cosmic:1102821, Cosmic:1139227, Cosmic:1305310, Cosmic:1312190, Cosmic:1707569, Cosmic:1709259, Cosmic:2186585, Cosmic:2301585, Cosmic-CLP:906825, DepMap:ACH-000713, EGA:EGAS00001000610, GDSC:906825, GEO:GSM184398, GEO:GSM184399, GEO:GSM274705, GEO:GSM313711, GEO:GSM459740, GEO:GSM659371, GEO:GSM711712, GEO:GSM784569, GEO:GSM851913, GEO:GSM886918, GEO:GSM887984, GEO:GSM1001485, GEO:GSM1291130, GEO:GSM1669661, GEO:GSM3161712, GEO:GSM3161713, IARC_TP53:1416, IARC_TP53:28485, IARC_TP53:30197, IGRhCellID:CaOv3, IZSLER:BS TCL 165, KCB:KCB 2013041YJ, LiGeA:CCLE_499, LINCS_LDP:LCL-1519, PharmacoDB:Caov3_182_2019, PRIDE:PXD003668, PRIDE:PXD030304, Progenetix:CVCL_0201, PubChem_Cell_line:CVCL_0201, Ubigene:YC-C031, Wikidata:Q54808585 |
|
|
CVCL_0201 |
2026-08-15 04:19:59 |
250 |